A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

被引:30
作者
Allerton, Charlotte M. N. [1 ]
Arcari, Joel T. [2 ]
Aschenbrenner, Lisa M. [2 ]
Avery, Melissa [2 ]
Bechle, Bruce M. [2 ]
Behzadi, Mohammad Amin [3 ]
Boras, Britton [4 ]
Buzon, Leanne M. [2 ]
Cardin, Rhonda D. [3 ]
Catlin, Natasha R. [2 ]
Carlo, Anthony A. [2 ]
Coffman, Karen J. [2 ]
Dantonio, Alyssa [2 ]
Di, Li [2 ]
Eng, Heather [2 ]
Farley, Kathleen A. [2 ]
Ferre, Rose Ann [4 ]
Gernhardt, Steven S. [2 ]
Gibson, Scott A. [5 ]
Greasley, Samantha E. [4 ]
Greenfield, Siennah R. [1 ]
Hurst, Brett L. [5 ]
Kalgutkar, Amit S. [1 ]
Kimoto, Emi [2 ]
Lanyon, Lorraine F. [2 ]
Lovett, Gabrielle H. [1 ]
Lian, Yajing [2 ]
Liu, Wei [4 ]
Alsina, Luis A. Martinez [2 ]
Noell, Stephen [2 ]
Obach, R. Scott [2 ]
Owen, Dafydd R. [1 ]
Patel, Nandini C. [1 ]
Rai, Devendra K. [2 ]
Reese, Matthew R. [2 ]
Rothan, Hussin A. [3 ]
Sakata, Sylvie [4 ]
Sammons, Matthew F. [1 ]
Sathish, Jean G. [3 ]
Sharma, Raman [2 ]
Steppan, Claire M. [2 ]
Tuttle, Jamison B. [1 ]
Verhoest, Patrick R. [1 ]
Wei, Liuqing [2 ]
Yang, Qingyi [1 ]
Yurgelonis, Irina [3 ]
Zhu, Yuao [3 ]
机构
[1] Pfizer Res & Dev, Cambridge, MA 02139 USA
[2] Pfizer Res & Dev, Groton, CT 06340 USA
[3] Pfizer Res & Dev, Pearl River, NY 10965 USA
[4] Pfizer Res & Dev, La Jolla, CA 92121 USA
[5] Utah State Univ, Inst Antiviral Res, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA
关键词
ALCOHOLS; ASSAYS;
D O I
10.1021/acs.jmedchem.3c02469
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Despite the record-breaking discovery, development and approval of vaccines and antiviral therapeutics such as Paxlovid, coronavirus disease 2019 (COVID-19) remained the fourth leading cause of death in the world and third highest in the United States in 2022. Here, we report the discovery and characterization of PF-07817883, a second-generation, orally bioavailable, SARS-CoV-2 main protease inhibitor with improved metabolic stability versus nirmatrelvir, the antiviral component of the ritonavir-boosted therapy Paxlovid. We demonstrate the in vitro pan-human coronavirus antiviral activity and off-target selectivity profile of PF-07817883. PF-07817883 also demonstrated oral efficacy in a mouse-adapted SARS-CoV-2 model at plasma concentrations equivalent to nirmatrelvir. The preclinical in vivo pharmacokinetics and metabolism studies in human matrices are suggestive of improved oral pharmacokinetics for PF-07817883 in humans, relative to nirmatrelvir. In vitro inhibition/induction studies against major human drug metabolizing enzymes/transporters suggest a low potential for perpetrator drug-drug interactions upon single-agent use of PF-07817883.
引用
收藏
页码:13550 / 13571
页数:22
相关论文
共 27 条
[1]  
[Anonymous], WHO COVID 10 DASHBOA
[2]   Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding [J].
Banker, MJ ;
Clark, TH ;
Williams, JA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) :967-974
[3]  
Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]
[4]   SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies [J].
Cox, MacGregor ;
Peacock, Thomas P. ;
Harvey, William T. ;
Hughes, Joseph ;
Wright, Derek W. ;
Willett, Brian J. ;
Thomson, Emma ;
Gupta, Ravindra K. ;
Peacock, Sharon J. ;
Robertson, David L. ;
Carabelli, Alessandro M. .
NATURE REVIEWS MICROBIOLOGY, 2023, 21 (02) :112-124
[5]   Development of a New Permeability Assay Using Low-Efflux MDCKII Cells [J].
Di, Li ;
Whitney-Pickett, Carrie ;
Umland, John P. ;
Zhang, Hui ;
Zhang, Xun ;
Gebhard, David F. ;
Lai, Yurong ;
Federico, James J., III ;
Davidson, Ralph E. ;
Smith, Russ ;
Reyner, Eric L. ;
Lee, Caroline ;
Feng, Bo ;
Rotter, Charles ;
Varma, Manthena V. ;
Kempshall, Sarah ;
Fenner, Katherine ;
El-Kattan, Ayman F. ;
Liston, Theodore E. ;
Troutman, Matthew D. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (11) :4974-4985
[6]   Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and HumansS [J].
Eng, Heather ;
Dantonio, Alyssa L. ;
Kadar, Eugene P. ;
Obach, R. Scott ;
Di, Li ;
Lin, Jian ;
Patel, Nandini C. ;
Boras, Britton ;
Walker, Gregory S. ;
Novak, Jonathan J. ;
Kimoto, Emi ;
Singh, Ravi Shankar P. ;
Kalgutkar, Amit S. .
DRUG METABOLISM AND DISPOSITION, 2022, 50 (05) :576-590
[7]   Species differences in plasma protein binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease inhibitor nirmatrelvir [J].
Greenfield, Siennah R. R. ;
Eng, Heather ;
Yang, Qingyi ;
Guo, Chunyang ;
Byrnes, Laura ;
Dantonio, Alyssa ;
West, Graham ;
Di, Li ;
Kalgutkar, Amit S. S. .
XENOBIOTICA, 2023, 53 (01) :12-24
[8]   Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 [J].
Hammond, Jennifer ;
Leister-Tebbe, Heidi ;
Gardner, Annie ;
Abreu, Paula ;
Bao, Weihang ;
Wisemandle, Wayne ;
Baniecki, MaryLynn ;
Hendrick, Victoria M. ;
Damle, Bharat ;
Simon-Campos, Abraham ;
Pypstra, Rienk ;
Rusnak, James M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) :1397-1408
[9]   Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir [J].
Jiang, Xiangrui ;
Su, Haixia ;
Shang, Weijuan ;
Zhou, Feng ;
Zhang, Yan ;
Zhao, Wenfeng ;
Zhang, Qiumeng ;
Xie, Hang ;
Jiang, Lei ;
Nie, Tianqing ;
Yang, Feipu ;
Xiong, Muya ;
Huang, Xiaoxing ;
Li, Minjun ;
Chen, Ping ;
Peng, Shaoping ;
Xiao, Gengfu ;
Jiang, Hualiang ;
Tang, Renhong ;
Zhang, Leike ;
Shen, Jingshan ;
Xu, Yechun .
NATURE COMMUNICATIONS, 2023, 14 (01)
[10]   A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice [J].
Leist, Sarah R. ;
Dinnon, Kenneth H. ;
Schafer, Alexandra ;
Tse, Longping, V ;
Okuda, Kenichi ;
Hou, Yixuan J. ;
West, Ande ;
Edwards, Caitlin E. ;
Sanders, Wes ;
Fritch, Ethan J. ;
Gully, Kendra L. ;
Scobey, Trevor ;
Brown, Ariane J. ;
Sheahan, Timothy P. ;
Moorman, Nathaniel J. ;
Boucher, Richard C. ;
Gralinski, Lisa E. ;
Montgomery, Stephanie A. ;
Baric, Ralph S. .
CELL, 2020, 183 (04) :1070-+